Mel-OD Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Concise Prescribing Info

Contents

Meloxicam

Indications/Uses

OA, RA & ankylosing spondylitis.

Click to view Mel-OD detailed prescribing information

Dosage/Direction for Use

OA 7.5 mg once daily, may be increased to 15 mg once daily. RA, ankylosing spondylitis Initially & not to exceed 15 mg once daily. May be reduced to 7.5 mg once daily.

Click to view Mel-OD detailed prescribing information

Administration

Should be taken with food.

Contraindications

Hypersensitivity. Bleeding disorders & active or recent peptic ulcer; severe uncontrolled heart failure. Severe hepatic insufficiency. Non-dialysed severe renal insufficiency. Pregnancy & lactation. Childn <15 yr.

Click to view Mel-OD detailed prescribing information

Special Precautions

Serious GI reactions including bleeding, stomach or intestines ulceration & perforation. Patients w/ history of GI disease & on anticoagulants; CV disease or risk factors for CV disease. Increased risk of serious CV thrombotic events, MI & stroke. Frail or debilitated patients. Elderly.

Click to view Mel-OD detailed prescribing information

Adverse Reactions

Dyspepsia, nausea, vomiting, abdominal pain, constipation, flatulence, diarrhea, raised transaminases or bilirubin, eructation, oesophagitis, gastroduodenal ulcer, occult or macroscopic GI bleeding; anaemia, blood count disturbances, leucopenia, thrombocytopenia; pruritus, skin rash, urticaria, stomatitis, photosensitization, bullous reactions, erythema multiforme, SJS, TEN; acute asthma; lightheadedness, vertigo, headache, tinnitus, drowsiness; oedema, increased BP, palpitations, flushes; increased serum creatinine &/or urea, acute renal failure; conjunctivitis, visual disturbances including blurred vision.

Click to view Mel-OD detailed prescribing information

Drug Interactions

Increased clearance w/ cholestyramine. Reduced antihypertensive effect of β-blockers, ACE inhibitors, vasodilators, diuretics. Increased risk of bleeding w/ oral anticoagulants.

Click to view Mel-OD detailed prescribing information

Storage

View Mel-OD storage conditions for details to ensure optimal shelf-life.

Description

View Mel-OD description for details of the chemical structure and excipients (inactive components).

Action

View Mel-OD mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

ATC Classification

M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, oxicams.

Thai FDA Category

Presentation/Packing

Form

Mel-OD tab 15 mg

Packing/Price

10 × 10's

Form

Mel-OD tab 7.5 mg

Packing/Price

10 × 10's

Mel-OD

meloxicam

Manufacturer:

Zydus Cadila

Distributor:

Pharmadica